Laidlaw Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-20,793
| Closed | -$683K | – | 368 |
|
|
2022
Q3 | $683K | Sell |
20,793
-77
| -0.4% | -$2.53K | 0.16% | 141 |
|
|
2022
Q2 | $657K | Buy |
20,870
+5,702
| +38% | +$180K | 0.13% | 165 |
|
|
2022
Q1 | $697K | Buy |
15,168
+4,368
| +40% | +$201K | 0.12% | 178 |
|
|
2021
Q4 | $661K | Buy |
10,800
+358
| +3% | +$21.9K | 0.11% | 191 |
|
|
2021
Q3 | $780K | Sell |
10,442
-500
| -5% | -$37.3K | 0.2% | 109 |
|
|
2021
Q2 | $1.01M | Buy |
10,942
+5,707
| +109% | +$528K | 0.26% | 94 |
|
|
2021
Q1 | $465K | Buy |
5,235
+718
| +16% | +$63.8K | 0.16% | 129 |
|
|
2020
Q4 | $421K | Buy |
+4,517
| New | +$421K | 0.09% | 212 |
|